Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Median Approval Time Drops To 11.6 Months For FY 1999 Applications

Executive Summary

The median approval time for new product applications submitted in fiscal 1999 decreased to 11.6 months from 12 months in the prior three fiscal years, FDA's Prescription Drug User Fee Performance Report for FY 2000 states.
Advertisement

Related Content

King Altace Physician Promotion Emphasized For 2001; DTC Delayed To 2002
King Altace Physician Promotion Emphasized For 2001; DTC Delayed To 2002
Pfizer, PhRMA See Signs Of Drug Approval "Slowdown" At FDA
Pfizer, PhRMA See Signs Of Drug Approval "Slowdown" At FDA
Advertisement
UsernamePublicRestriction

Register

PS037544

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel